Literature DB >> 3161976

Synergy between adjuvant arthritis and collagen-induced arthritis in rats.

J D Taurog, S S Kerwar, R A McReynolds, G P Sandberg, S L Leary, M L Mahowald.   

Abstract

Adjuvant arthritis (AA) in rats is susceptible to cell-mediated passive transfer. Collagen-induced arthritis (CIA) in rats is susceptible to passive transfer with antibody to type II collagen. We report here the development of strikingly severe arthritis in Lewis rats as the result of synergy between passively transferred antibody to type II collagen from rats with CIA and concanavalin A (Con A)-stimulated lymph node or spleen cells from syngeneic rats with AA. Similar synergy was seen in rats with AA given anticollagen antibody, in rats with CIA given Con A-stimulated adjuvant spleen cells, and in rats actively immunized with CII and complete Freund's adjuvant. The synergistic process caused a very severe polyarthritis, characterized by marked swelling and erythema in all the joints of the distal extremities, with histologic and radiographic evidence of early, extensive erosion of articular cartilage. Synergy was apparent if the lymphoid cells from AA rats were given up to 1 mo after a single injection of anticollagen antibody. No synergy was seen when normal rat immunoglobulin or anti-ovalbumin antibody was substituted for anticollagen antibody, when Con A-stimulated lymphoid cells from normal rats or donors with CIA were used, or when Con A-stimulated AA lymphoid cells were irradiated before transfer. Synergy between separate immune effector mechanisms may represent a general phenomenon in the pathogenesis of inflammatory joint disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161976      PMCID: PMC2187796          DOI: 10.1084/jem.162.3.962

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS BY LYMPH NODE OR SPLEEN CELLS.

Authors:  C M PEARSON; F D WOOD
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

2.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS IN RATS WITH LIVING LYMPHOID CELLS OF SENSITIZED DONORS.

Authors:  B H WAKSMAN; C WENNERSTEN
Journal:  Int Arch Allergy Appl Immunol       Date:  1963

3.  Immunogenetic control of experimental collagen-induced arthritis in rats. II. ECIA susceptibility and immune response to type II collagen (CALF) are linked to RT1.

Authors:  M M Griffiths; C W DeWitt
Journal:  J Immunogenet       Date:  1981-12

4.  Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease.

Authors:  F Quagliata; J M Phillips-Quagliata
Journal:  Cell Immunol       Date:  1972-01       Impact factor: 4.868

5.  Adjuvant arthritis in the rat. Distribution of fluorescent material after footpad injection of rhodamine-labelled tubercle bacilli.

Authors:  B Vernon-Roberts; S P Liyanage; H L Currey
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

6.  The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer.

Authors:  J D Taurog; G P Sandberg; M L Mahowald
Journal:  Cell Immunol       Date:  1983-08       Impact factor: 4.868

7.  The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by concanavalin A and by immunosuppressive pretreatment of the recipient.

Authors:  J D Taurog; G P Sandberg; M L Mahowald
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

8.  Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II.

Authors:  J Holoshitz; A Matitiau; I R Cohen
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

9.  Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis.

Authors:  J M Stuart; M A Cremer; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  13 in total

1.  Modulation of immune and inflammatory responses on experimental arthritis following intraarticular gene transfer of tumor necrosis factor receptor-immunoglobulin Fc.

Authors:  Xiaobing Zhou; Kai Gao; Lianzhong Shen; Aizhi Zhao; Xiaobing Wu; Chao Wang; Junzhi Wang; Bo Li
Journal:  Rheumatol Int       Date:  2011-07-21       Impact factor: 2.631

2.  N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action.

Authors:  R M Burch; M Weitzberg; N Blok; R Muhlhauser; D Martin; S G Farmer; J M Bator; J R Connor; M Green; C Ko
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

3.  Activation of macrophages in an experimental rat model of arthritis induced by Erysipelothrix rhusiopathiae infection.

Authors:  H Renz; U Gentz; A Schmidt; T Dapper; M Nain; D Gemsa
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

Review 4.  What can we learn about rheumatoid arthritis from animal models?

Authors:  L Klareskog
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Prevention of pristane-induced arthritis by the oral administration of type II collagen.

Authors:  S J Thompson; H S Thompson; N Harper; M J Day; A J Coad; C J Elson; N A Staines
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

6.  Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage.

Authors:  H E Jasin; J D Taurog
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

7.  Immunity to type IX collagen in rodents: a study of type IX collagen for autoimmune and arthritogenic activities.

Authors:  M A Cremer; X J Ye; K Terato; M M Griffiths; W C Watson; A H Kang
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

Review 8.  Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.

Authors:  Brad Bolon; Marina Stolina; Caroline King; Scot Middleton; Jill Gasser; Debra Zack; Ulrich Feige
Journal:  J Biomed Biotechnol       Date:  2010-12-28

9.  The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis.

Authors:  Jorge M Santos; Rita N Bárcia; Sandra I Simões; Manuela M Gaspar; Susana Calado; Ana Agua-Doce; Sílvia C P Almeida; Joana Almeida; Mariana Filipe; Mariana Teixeira; José P Martins; Luís Graça; Maria E M Cruz; Pedro Cruz; Helder Cruz
Journal:  J Transl Med       Date:  2013-01-17       Impact factor: 5.531

10.  Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.

Authors:  E A Ranheim; T J Kipps
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.